Rodrigo Navarro Ramirez, MD

Appointed
2024

Education & Fellowships

Fellowship - Weill Cornell Medical College
Minimally Invasive Spine Surgery
New York, NY United States
2022

Fellowship - McGill University
Adult and Pediatric Scoliosis and Spine Surgery
Montreal Quebec, Canada
2020

Residency - UNAM HGM
Neurosurgery 6-year program
Mexico City, DF Mexico
2014

Graduate School - CINVESTAV
Master in Sciences (Neuroscience)
Mexico
2008

Medical Education - Universidad Autonoma del Estado de Morelos - Facultad de Medicina
Cuernavaca, Mor Mexico
2006

Additional Training

• Minimally Invasive Spine Surgery
• Adult Scoliosis Surgery 
• Pediatric Scoliosis Surgery

Professional Highlights

• Dr. Navarro-Ramirez has published more than 60 articles, many book chapter and one of his major accomplishments includes co-editing Essential Step-by-Step Techniques for Minimally Invasive Spinal Surgery alongside Dr. Roger Härtl. This comprehensive text serves as a key resource for spine surgeons globally, focusing on advanced techniques for minimally invasive spine surgery. It highlights what they term the "six T's"—Target, Technology, Technique, Training, Testing, and Talent—essential for mastering these complex procedures. His innovative contributions to spinal surgery techniques have earned him recognition, such as the Best Basic Research at the AO Spine North America Fellows Forum competing against a generation of spine specialists.

  His work is driven by a commitment to improving patient outcomes through cutting-edge surgical techniques and ongoing educational efforts within the global spine surgery community.

Awards & Honors

• Best Young Researcher - Lateral Access Surgery
• Best Basic Research - AO Spine North America

Innovations & Patents

• Cervical spine tissue-engineered disc replacement
• Bioglue for disc lumbar disc herniations
• Bioabsorbable implant combined with tissue-engineered composite intervertebral disc. Patent #11903843

Memberships

• NASS
• AANS
• CNS
• FNS
• AO Spine

See publications for Rodrigo Navarro Ramirez, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/20/2024, Dr. Navarro Ramirez has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.